Weekly Digest – June 2024 Weekly Digest – June 2024 20 June 2024: Tubulis Doses First Patient in Phase I/IIa Trial Investigating ADC Candidate TUB-040 in Ovarian Cancer and Lung Adenocarcinoma Tubulis has initiated a Phase I/IIa trial (NAPISTAR 1-01, […]
Weekly Digest – June 2024 Weekly Digest – June 2024 18 June 2024: Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers Day One Biopharmaceuticals has secured […]
Weekly Digest – June 2024 Weekly Digest – June 2024 17 June 2024: FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths The FDA halted a phase 1 trial (NCT05653752) of BNT326/YL202, a MediLink Therapeutics’ BioNTech-partnered ADC, […]
